Proposition 303: Medical Product Authorization for Terminally Ill Patients Initiative
Passed with 78.5% yes.
- Yes
- 1,111,850
- 78.5%. The passing rule is not on file.
- No
- 304,971
- 21.5%
Qualified (Done)
On the ballot (Done)
Election day (Done)
Passed (Done)
What a yes vote does
Permit drug and medical device manufacturers to make products available to terminally ill patients that have completed phase one of a clinical trial but have not yet been approved by the U.S. Food and Drug Administration.
What moved
How it got on the ballot
The legislature put it before voters.
In the news
Reporting that may mention this subject. Possible matches are labeled.
Loading coverage…